Drug Trial Radar · NCT06551324
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
609
Actual
Start
Oct 21, 2024
Primary completion
Feb 28, 2027
Study completion Oct 29, 2028
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 13, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pfizer MEVPRO-1 (C2321014) is a randomized, open-label, multi-center clinical trial evaluating whether combining the study medicine (PF-06821497) with enzalutamide is safe and effective compared to physician's choice of either second-line androgen receptor (AR) directed therapy with enzalutamide or docetaxel (chemotherapy) for treating metastatic castration-resistant prostate cancer (mCRPC) after progression on prior abiraterone acetate treatment. The primary objective of this clinical trial is to assess the radiographic progression free survival (rPFS) of the combination of PF-06821497 plus enzalutamide versus physician's choice of enzalutamide or docetaxel.
Conditions
- Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Interventions
PF-06821497Drug
875 mg BID (2 times a day)
DocetaxelDrug
75 mg/m2 IV (every 21 days)
EnzalutamideDrug
160 mg QD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Radiographic Progression Free Survival (rPFS) assessed by blinded independent central review (BICR) per RECIST v1.1 and Prostate Cancer Clinical Trials Working Group 3 (PCWG3)Time frame: Randomization up to approximately 2 years.
Locations
224 sites in 23 countries. Site status is shown where the registry gives one.
Urology Centers of Alabama
Homewood, Alabama
Ironwood Cancer & Research Centers
Chandler, Arizona
Ironwood Cancer & Research Centers
Gilbert, Arizona
Ironwood Cancer & Research Centers
Glendale, Arizona
Ironwood Cancer & Research Centers
Mesa, Arizona
Ironwood Cancer & Research Centers
Mesa, Arizona
Ironwood Cancer & Research Centers
Phoenix, Arizona
Ironwood Cancer & Research Centers
Scottsdale, Arizona
Los Angeles Cancer Network
Anaheim, California
UCSF Cancer Center Berkeley
Berkeley, California
UCSF Cancer Center Burlingame
Burlingame, California
Los Angeles Cancer Network
Fountain Valley, California
Los Angeles Cancer Network
Glendale, California
Los Angeles Cancer Network
Glendale, California
Los Angeles Cancer Network
Los Angeles, California
Los Angeles Cancer Network
Los Angeles, California
Stanford Cancer Center
Palo Alto, California
UCSF Investigational Drug Pharmacy
San Francisco, California
UCSF Medical Center at Mission Bay
San Francisco, California
UCSF Cancer Center San Mateo
San Mateo, California
Sutter Santa Rosa
Santa Rosa, California
Stanford Health Care Attention: Investigational Pharmacy
Stanford, California
Colorado Clinical Research
Lakewood, Colorado
University of Miami Sylvester Comprehensive Cancer Center - Aventura
Aventura, Florida
Florida Cancer Specialists
Bradenton, Florida
Florida Cancer Specialists
Cape Coral, Florida
University of Miami Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
Coral Gables, Florida
University of Miami Sylvester Comprehensive Cancer Center - Deerfield Beach
Deerfield Beach, Florida
University of Miami Hospital and Clinics - Doral
Doral, Florida
Florida Cancer Specialists
Fort Myers, Florida
Florida Cancer Specialists
Fort Myers, Florida
University of Miami Sylvester Comprehensive Cancer Center - Kendall
Kendall, Florida
University of Miami Hospital and Clinics, Sylvester Cancer Center
Miami, Florida
University of Miami Hospital and Clinics, UHealth Tower
Miami, Florida
University of Miami Sylvester Comprehensive Cancer Center - Griffin Cancer Research Building
Miami, Florida
Florida Cancer Specialists
N. Venice, Florida
Florida Cancer Specialists
Naples, Florida
AdventHealth Hematology and Oncology
Orlando, Florida
AdventHealth Orlando Infusion Center
Orlando, Florida
University of Miami Sylvester Comprehensive Cancer Center - Plantation
Plantation, Florida
Showing 40 of 224 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.